Summary
We have previously shown that receptors for advanced glycation end products are expressed on activated human monocytes. We now report that activated human monocytes exhibit increased adhesion to non-enzymatically glycated collagen substrates (+32%±1, p<0.001), and the increased adhesion can be competitively inhibited with non-enzymatically glycated albumin. Non-activated monocytes, which do not express receptors for advanced glycation end products, exhibit decreased adhesion (-16%±1, p<0.001). Similar results were observed with substrates of fibronectin and endothelial cell matrix proteins. As the presence of glycation adducts on collagen interferes with the normal binding of monocytes/macrophages, one possible role for advanced glycation adduct receptors on activated monocytes is to counterbalance such decreased adherence. Overcompensation for long periods of time may lead to pathological changes. Additionally, such receptors may play a role in monocyte-mediated remodelling of glycated matrix proteins, as we have observed increased degradation of nonenzymatically glycated collagen substrates by activated human monocytes at 2 h (+52%±11, p=0.01), 3 h(+49% ±10, p=0.01), and 4 h (+36%±6, p<0.01) after adding activated monocytes to 125I-labelled substrates.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cerami A, Vlassara H, Brownlee M (1985) Protein glycosylation and the pathogenesis of atherosclerosis. Metab Clin Exp 12 [Suppl 1]: 37–42
Winterhalter KH (1985) Nonenzymatic glycosylation of proteins. Prog Clin Biol Res 195: 109–129
Vlassara H, Brownlee M, Cerami A (1986) Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 32 [Suppl 10]: B37–41
Brownlee M, Cerami A, Vlassara H (1988) Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4: 437–451
Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315–1321
Reynolds TM (1965) Chemistry of nonenzymatic browning. Adv Food Res 14: 167–283
Monnier VM, Cerami A (1981) Nonenzymatic browning in vivo: possible process for aging for long-lived proteins. Science 211: 491–493
Monnier VM, Cerami A (1982) Nonenzymatic glycosylation and browning of proteins in diabetes. Clin Endocrinol Metab 11: 431–452
Sakurai T, Takahashi H, Tsuchiya S (1984) New flourescence of nonenzymatically glycosylated human serum albumin. FEBS Lett 176: 27–31
Vlassara H, Brownlee M, Cerami A (1985) High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for removal of senescent macromolecules. Proc Natl Acad Sci USA 82: 5588–5592
Vlassara H, Brownlee M, Cerami A (1986) Novel macrophage receptor for glucose-modified proteins is distinct from previously-described scavenger receptors. J Exp Med 164: 1301–1309
Vlassara H, Moldawer L, Chan B (1989) Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. J Clin Invest 84: 1813–1820
Gilcrease MZ, Hoover RL (1990) Activated human monocytes exhibit receptor-mediated adhesion to a non-enzymatically glycosylated protein substrate. Diabetologia 33: 329–333
Radoff S, Vlassara H, Cerami A (1988) Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products. Arch Biochem Biophys 263: 418–423
Nicholls K, Mandel TE (1989) Advanced glycosylation end products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60: 486–491
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629–1632
Haudenschild CC (1984) Morphology of vascular endothelial cells in culture. In: Jaffe EA (ed) Biology of endothelial cells. Martinus Nijhoff, Boston, pp 129–140
Johnson AR (1980) Human pulmonary endothelial cells in culture. J Clin Invest 65: 841–850
Stein O, Stein Y (1980) Bovine aortic cells display macrophage-like properties toward acetylated (I-125)-labeled low density lipoprotein. Biochim Biophys Acta 620: 631–635
Fraker PJ, Speck JC (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Comm 80: 849–857
Vlassara H, Brownlee M, Cerami A (1988) Specific macrophage receptor activity for advance glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37: 456–461
Harlan JM (1985) Leukocyte-endothelial interactions. Blood 65: 513–525
Banga JD, Sixma JJ (1986) Diabetes mellitus, vascular disease and thrombosis. Clin Haematol 15: 465–491
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilcrease, M.Z., Hoover, R.L. Human monocyte interactions with non-enzymatically glycated collagen. Diabetologia 35, 160–164 (1992). https://doi.org/10.1007/BF00402549
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402549